Consun Pharmaceutical Group Limited (1681.HK)

HKD 9.64

(4.1%)

Operating Expenses Summary of Consun Pharmaceutical Group Limited

  • Consun Pharmaceutical Group Limited's latest annual operating expenses in 2023 was 1.03 Billion CNY , up 3.88% from previous year.
  • Consun Pharmaceutical Group Limited's latest quarterly operating expenses in 2024 Q2 was 500.19 Million CNY , down 0.0% from previous quarter.
  • Consun Pharmaceutical Group Limited reported a annual operating expenses of 1.05 Billion CNY in annual operating expenses 2022, up 23.34% from previous year.
  • Consun Pharmaceutical Group Limited reported a annual operating expenses of 857.81 Million CNY in annual operating expenses 2021, up 15.23% from previous year.
  • Consun Pharmaceutical Group Limited reported a quarterly operating expenses of 1.09 Billion CNY for 2023 FY, up 3.88% from previous quarter.
  • Consun Pharmaceutical Group Limited reported a quarterly operating expenses of 585.1 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Consun Pharmaceutical Group Limited (2023 - 2012)

Historical Annual Operating Expenses of Consun Pharmaceutical Group Limited (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 1.03 Billion CNY 3.88%
2022 1.05 Billion CNY 23.34%
2021 857.81 Million CNY 15.23%
2020 744.42 Million CNY -33.6%
2019 1.12 Billion CNY 48.19%
2018 756.51 Million CNY 11.95%
2017 675.78 Million CNY 32.67%
2016 509.36 Million CNY 33.04%
2015 382.87 Million CNY 13.82%
2014 336.39 Million CNY 36.75%
2013 245.98 Million CNY 46.39%
2012 168.04 Million CNY 0.0%

Peer Operating Expenses Comparison of Consun Pharmaceutical Group Limited

Name Operating Expenses Operating Expenses Difference
Pak Fah Yeow International Limited 24.42 Million HKD -4144.641%
Grand Pharmaceutical Group Limited 3.86 Billion HKD 73.147%
Extrawell Pharmaceutical Holdings Limited 35.52 Million HKD -2818.093%
Wai Yuen Tong Medicine Holdings Limited 353.93 Million HKD -192.912%
Qianhai Health Holdings Limited 17.1 Million HKD -5961.928%
Lee's Pharmaceutical Holdings Limited 590.99 Million HKD -75.419%
Essex Bio-Technology Limited 1.22 Billion HKD 15.643%
Tongfang Kontafarma Holdings Limited 503.46 Million HKD -105.916%
PuraPharm Corporation Limited 216.62 Million HKD -378.565%
SSY Group Limited 1.98 Billion HKD 47.66%
JBM (Healthcare) Limited 163.87 Million HKD -532.619%
Jacobson Pharma Corporation Limited 287.34 Million HKD -260.785%
China Resources Pharmaceutical Group Limited 29.35 Billion HKD 96.468%